AHR and melanoma: Among, the analyzed melanoma samples (n = 454), 17% of Patients strongly expressing AhR‐associated resistance genes (red box) showed significantly lower overall survival than those highly expressing genes for sensitivity (blue box; Appendix Fig S3A).